Financing From Single Existing Institutional Shareholder BETHESDA, Md., Oct. 7, 2014 /PRNewswire/ — Northwest Biotherapeutics (NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, Continue Reading…